Related Experiment Video
Updated: Sep 26, 2026

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
Published on: January 12, 2020
Expression of Smac/DIABLO in ovarian carcinoma cells induces apoptosis via a caspase-9-mediated pathway
1Cancer Research UK Molecular Oncology Unit, Imperial College School of Medicine, Hammersmith Hospital, W12 ONN, London, UK. iain.mcneish@cancer.org.uk
Abstract:
We have constructed Ad CMV-Smac, a recombinant adenovirus encoding Smac/DIABLO, the recently described second mitochondrial activator of caspases. Transfection of ovarian carcinoma cells with Ad CMV-Smac at multiplicities of infection of 3-60 pfu/cell leads to increasing apoptosis in a dose-dependent manner. Western blot analysis confirms that Smac-induced apoptosis proceeds via a pathway mediated primarily by caspase-9 that can be inhibited by zLEHD-fmk and overexpression of the X-linked inhibitor of apoptosis protein (XIAP). In contrast, there is no cleavage of either caspase-8 or caspase-12. Ad CMV-Smac appears to induce apoptosis independently of cytochrome c release from mitochondria and is not inhibited by overexpression of Bcl-2. Ad CMV-Smac can combine with other proapoptotic factors, such as cisplatin, paclitaxel, and procaspase-3, to produce greater levels of apoptosis in transfected cells.
Insights
We engineered a virus to deliver Smac/DIABLO, a protein that triggers programmed cell death (apoptosis). This virus effectively induced apoptosis in ovarian cancer cells, offering a potential new cancer therapy.
Area of Science:
- Molecular Biology
- Cell Biology
- Oncology
Background:
- Smac/DIABLO is a mitochondrial protein that promotes apoptosis by antagonizing inhibitors of apoptosis proteins.
- Recombinant adenoviruses are effective vectors for gene delivery in cancer therapy.
Purpose of the Study:
- To construct and evaluate a recombinant adenovirus encoding Smac/DIABLO (Ad CMV-Smac) for its ability to induce apoptosis in ovarian carcinoma cells.
- To elucidate the apoptotic pathway activated by Ad CMV-Smac.
Main Methods:
- Construction of Ad CMV-Smac, a recombinant adenovirus encoding Smac/DIABLO.
- Transfection of ovarian carcinoma cells with Ad CMV-Smac at varying multiplicities of infection.
- Western blot analysis to assess caspase activation and apoptosis markers.
- Inhibition studies using zLEHD-fmk and XIAP overexpression.
Main Results:
- Ad CMV-Smac induced apoptosis in ovarian carcinoma cells in a dose-dependent manner.
- Smac-induced apoptosis was mediated primarily by caspase-9 and could be inhibited by zLEHD-fmk and XIAP.
- Apoptosis was independent of cytochrome c release and Bcl-2 overexpression.
- Ad CMV-Smac enhanced apoptosis when combined with cisplatin, paclitaxel, or procaspase-3.
Conclusions:
- Ad CMV-Smac is a potent inducer of apoptosis in ovarian cancer cells via a caspase-9-dependent pathway.
- Smac/DIABLO delivery using adenovirus shows promise as a therapeutic strategy for ovarian cancer, potentially in combination with other agents.
Related Concept Videos
The Intrinsic Apoptotic Pathway
The Extrinsic Apoptotic Pathway
Caspases
Apoptosis

